Medrio is a San Francisco-based healthcare technology company that provides eClinical solutions and its CloudEDC electronic data-capture platform for clinical trials. Founded in 2005 by CEO Mike Novotny, the CloudEDC features a drag-and-drop interface enabling quick study builds. Its platform has been used in over 2,000 clinical trials worldwide by more than 500 customers. Medrio recently introduced new software applications including eSource, ePRO and eConsent. The company raised $30m in its first institutional equity funding and will use the proceeds to accelerate deployment of its new applications and expand its market position in the eClinical space. In conjunction with the investment, two Questa Capital principals joined Medrio's board.

Total raised

$30M

Funding rounds

1

Latest round

Equity

Latest activity

May 2017